These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 19484221
1. Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration--comparison with CB(1) receptor blockade. Forget B, Coen KM, Le Foll B. Psychopharmacology (Berl); 2009 Sep; 205(4):613-24. PubMed ID: 19484221 [Abstract] [Full Text] [Related]
2. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats. Forget B, Guranda M, Gamaleddin I, Goldberg SR, Le Foll B. Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774 [Abstract] [Full Text] [Related]
3. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. Cippitelli A, Cannella N, Braconi S, Duranti A, Tontini A, Bilbao A, Defonseca FR, Piomelli D, Ciccocioppo R. Psychopharmacology (Berl); 2008 Jul; 198(4):449-60. PubMed ID: 18446329 [Abstract] [Full Text] [Related]
4. Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats. Scherma M, Panlilio LV, Fadda P, Fattore L, Gamaleddin I, Le Foll B, Justinová Z, Mikics E, Haller J, Medalie J, Stroik J, Barnes C, Yasar S, Tanda G, Piomelli D, Fratta W, Goldberg SR. J Pharmacol Exp Ther; 2008 Nov; 327(2):482-90. PubMed ID: 18725543 [Abstract] [Full Text] [Related]
5. Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys. Schindler CW, Scherma M, Redhi GH, Vadivel SK, Makriyannis A, Goldberg SR, Justinova Z. Psychopharmacology (Berl); 2016 May; 233(10):1867-77. PubMed ID: 26803499 [Abstract] [Full Text] [Related]
8. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability. Gueye AB, Pryslawsky Y, Trigo JM, Poulia N, Delis F, Antoniou K, Loureiro M, Laviolette SR, Vemuri K, Makriyannis A, Le Foll B. Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155 [Abstract] [Full Text] [Related]
9. Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice. Kinsey SG, Naidu PS, Cravatt BF, Dudley DT, Lichtman AH. Pharmacol Biochem Behav; 2011 Oct; 99(4):718-25. PubMed ID: 21740924 [Abstract] [Full Text] [Related]
10. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety. Danandeh A, Vozella V, Lim J, Oveisi F, Ramirez GL, Mears D, Wynn G, Piomelli D. Psychopharmacology (Berl); 2018 Nov; 235(11):3211-3221. PubMed ID: 30251159 [Abstract] [Full Text] [Related]
11. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Moreira FA, Kaiser N, Monory K, Lutz B. Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120 [Abstract] [Full Text] [Related]
12. Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception. Naidu PS, Booker L, Cravatt BF, Lichtman AH. J Pharmacol Exp Ther; 2009 Apr; 329(1):48-56. PubMed ID: 19118134 [Abstract] [Full Text] [Related]
13. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. Melis M, Pillolla G, Luchicchi A, Muntoni AL, Yasar S, Goldberg SR, Pistis M. J Neurosci; 2008 Dec 17; 28(51):13985-94. PubMed ID: 19091987 [Abstract] [Full Text] [Related]
14. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms. Bosier B, Muccioli GG, Lambert DM. Br J Pharmacol; 2013 Jun 17; 169(4):794-807. PubMed ID: 22970888 [Abstract] [Full Text] [Related]
15. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice. Russo R, Loverme J, La Rana G, Compton TR, Parrott J, Duranti A, Tontini A, Mor M, Tarzia G, Calignano A, Piomelli D. J Pharmacol Exp Ther; 2007 Jul 17; 322(1):236-42. PubMed ID: 17412883 [Abstract] [Full Text] [Related]
16. An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters. Moise AM, Eisenstein SA, Astarita G, Piomelli D, Hohmann AG. Psychopharmacology (Berl); 2008 Oct 17; 200(3):333-46. PubMed ID: 18545985 [Abstract] [Full Text] [Related]
17. The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine-induced vomiting in the Suncus murinus (house musk shrew). Parker LA, Limebeer CL, Rock EM, Litt DL, Kwiatkowska M, Piomelli D. Physiol Behav; 2009 Apr 20; 97(1):121-4. PubMed ID: 19239915 [Abstract] [Full Text] [Related]
18. The effects of fatty acid amide hydrolase inhibitors on maintenance of cocaine and food self-administration and on reinstatement of cocaine-seeking and food-taking behavior in rats. Adamczyk P, McCreary AC, Przegalinski E, Mierzejewski P, Bienkowski P, Filip M. J Physiol Pharmacol; 2009 Sep 20; 60(3):119-25. PubMed ID: 19826190 [Abstract] [Full Text] [Related]
19. Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys. Schindler CW, Redhi GH, Vemuri K, Makriyannis A, Le Foll B, Bergman J, Goldberg SR, Justinova Z. Neuropsychopharmacology; 2016 Aug 20; 41(9):2283-93. PubMed ID: 26888056 [Abstract] [Full Text] [Related]
20. Endocannabinoid modulation of male rat sexual behavior. Gorzalka BB, Morrish AC, Hill MN. Psychopharmacology (Berl); 2008 Jul 20; 198(4):479-86. PubMed ID: 17694389 [Abstract] [Full Text] [Related] Page: [Next] [New Search]